Pancreatic Cancer is Deadly... ValAsta Can Help!

Research has shown that ValAsta / astaxanthin can be used to fight the gemcitabine-resistant pancreatic tumors.

Pancreatic cancer is a lethal malignancy, with a mortality rate of >90%; it is ranked fourth in terms of cancer-related deaths. Treatment of pancreatic cancer involves chemotherapy. The tumor rapidly becomes resistance to this treatment resulting in the cancer being difficult to treat and with a poor outcome. The attached study shows how astaxanthin can prevent the tumor from becoming resistant to the chemotherapy and allowing for a better outcome.  

Signs and symptoms of pancreatic cancer often don't occur until the disease is advanced.

Symptoms may include:

1. Pain in the upper abdomen that radiates to your back
2. Loss of appetite or unintended weight loss
3. Depression
4. New-onset diabetes
5. Blood clots
6. Fatigue
7. Yellowing of your skin and the whites of your eyes (jaundice)

Astaxanthin inhibits gemcitabine-resistant human pancreatic cancer progression through EMT inhibition and gemcitabine resensitization - PMC (nih.gov)